Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Ductal × Indocyanine Green × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 28 Neoplasms 12 Lung Neoplasms 11 Endometrial Neoplasms 10 Stomach Neoplasms 9 Head and Neck Neoplasms 7 Lymphatic Metastasis 6 Esophageal Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Melanoma 5 Carcinoma, Non-Small-Cell Lung 5 Colonic Neoplasms 4 Sarcoma 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Lymphedema 3 Colorectal Neoplasms 3 Brain Neoplasms 3 Vulvar Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solitary Pulmonary Nodule 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Osteosarcoma 2 Multiple Pulmonary Nodules 2 Margins of Excision 2 Giant Cell Tumor of Bone 2 Carcinoma, Squamous Cell 2

Interventions

trametinib 1 talimogene laherparepvec 1 spartalizumab 1 pembrolizumab 1 nazartinib 1 canakinumab 1 Telomerase 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sentinel Lymph Node Biopsy 1 Pemetrexed 1 Paclitaxel 1 Mastectomy, Subcutaneous 1 Mastectomy, Segmental 1 Mammaplasty 1 Letrozole 1 Indocyanine Green 1 Doxorubicin 1 Docetaxel 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡